Research

Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in
Treatment Resistant Depression. Poster presented at the ASKP3 2025 conference. Julia Engelhardt, Haley Cox, Krisha Shah, Brittany O’Brien, Charles Green, Jesse Wells, Allison Wells, Alan Swann1, Sanjay Mathew, Nicholas Murphy

Anti-suicidal effects of IV ketamine in a real-world setting. Poster presented at the ADAA 2024 conference. O’Brien, B., Lee, J., Kim, S., Nandra, G. S., Swann, A. C., Murphy, N., Averilla, L., Jha, M., Wells, I., Wells, M., & Mathew, S. J.

The effect of ketamine infusion treatment schedule on depression severity. Poster. O’Brien, B., Wells, A., Lijffijt, M., Davis, M., Wells, J., Swann, A. C., & Mathew, S. J. 

Does childhood trauma impact outcomes in adults receiving ketamine for depression? Poster. O’Brien, B., Wells, A., Lijffijt, M., Davis, M., Wells, J., & Mathew, S. J.